Multidrug-resistant tuberculosis
Clinical trials for Multidrug-resistant tuberculosis explained in plain language.
Never miss a new study
Get alerted when new Multidrug-resistant tuberculosis trials appear
Sign up with your email to follow new studies for Multidrug-resistant tuberculosis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with Drug-Resistant TB: delamanid studied in children
Disease control CompletedThis study tested the drug delamanid in 37 children with multidrug-resistant tuberculosis (MDR-TB), some of whom also had HIV. The goal was to see how the drug works in the body, check for side effects, and find the right dose. Children took delamanid along with their regular TB …
Matched conditions: MULTIDRUG-RESISTANT TUBERCULOSIS
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Can newer tests match the gold standard for detecting Drug-Resistant TB?
Diagnosis CompletedThis study evaluates whether two newer line probe assays, the YD REBA MTB-MDR and Hain Genotype MTBDRplus V2, perform as well as the older Hain Genotype MTBDRplus V1 in detecting drug-resistant tuberculosis. Researchers will test stored, de-identified samples from adults with sym…
Matched conditions: MULTIDRUG-RESISTANT TUBERCULOSIS
Sponsor: Foundation for Innovative New Diagnostics, Switzerland • Aim: Diagnosis
Last updated Sep 05, 2026 00:00 UTC